Continuing Education For Healthcare Professionals
FreeCE | PharmCon | Support | Forums | Blogs | Contact Us
Log In
 
 
Forgot Your Password
 
Facebook Twitter Blogs RSS feeds Forums
 
 
 
Skip Navigation Links > FreeCE > Calendar of Live CE Events > Program Details
 
More than Just a Headache: Current and Upcoming Treatment Strategies for Managing Migraines
Continuing Education Credits for Healthcare Professionals
 

Event Type
Live Online

Date
Monday, July 16, 2012

Time
10:30 AM ET To 11:30 AM ET

Location
PharmCon Webinar Studio

Credits
1 Contact Hour

Target Audience
Nurse, Pharmacist

Cost
$30.00 - Free For Members





Program Overview
Overview:  A migraine isn't just a bad headache.  It is a chronic neurological disorder characterized by moderate to severe headaches and nausea.  Worldwide, migraines affect more than 10% of people.  In the United States, about 18% of women and 6% of men experience a migraine in a given year.  Current pharmacologic treatments of acute migraine consist of nonspecific and relatively specific agents.  Although the advent of triptans in the 1990's signaled a significant advancement in the treatment of migraines, only one third of patients in clinical trials are pain-free 2 hours after taking a triptan orally, suggesting that novel treatment options are needed.  This presentation will provide an overview of the symptoms of migraines, review the currently available treatment options, and present  an overview of the novel therapies currently in clinical trials.

Nurse Educational Objectives
  • Recognize the signs and symptoms leading to a diagnosis of migraine, including the impact on quality of life.
  • Outline the non-pharmacologic and behavioral approaches for the treatment and/or prevention of migraines.
  • Review the current FDA approved pharmaceutical therapies used to treat migraine, including their mechanisms of action, efficacy, dosing, safety, and tolerability profiles.
  • Identify the novel classes of drugs currently in clinical trials for the treatment of migraines.
Pharmacist Educational Objectives
  • Recognize the signs and symptoms leading to a diagnosis of migraine, including the impact on quality of life.
  • Outline the non-pharmacologic and behavioral approaches for the treatment and/or prevention of migraines.
  • Review the current FDA approved pharmaceutical therapies used to treat migraine, including their mechanisms of action, efficacy, dosing, safety, and tolerability profiles.
  • Identify the novel classes of drugs currently in clinical trials for the treatment of migraines.
Repeat Presentation
This presentation was last given on Thursday, June 14, 2012

Activity Type
Knowledge

Accreditation
Nurse N-768
Pharmacist 0798-0000-12-043-L01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing education. In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.
Pharmaceutical Education Consultants, Inc. has been approved as a provider of continuing education for nurses by the Maryland Nurses Association which is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation.
Faculty
Karen L Milkiewicz , PhD, RPh
Research Scientist II, Teva Pharmaceuticals
Click Here For Curriculum Vitae


Financial Support Received From
Pharmaceutical Education Consultants, Inc.

Refund Policy
PharmCon provides full refunds of paid amounts if cancellations are made more than 24 hours prior to the scheduled time of the event and the request is submitted by email to: admin@pharmcon.com. Cancellations after that time will forfeit their registration fees.

Handouts
Reference: Table 1
Reference: Preventive Treatment for Migraine Table full size
Slide Document: More Than Just a Headache Slides
Cost
$30.00 - Free For Members

Program is Over

Registration Closed.
Test your computer for FreeCE.com compatibility

Computer sharing is NOT permitted due to ACPE guidelines on program monitoring. Credit is given to one user per computer.